SecB chaperones assist protein export by binding both unfolded proteins and the SecA motor. Certain SecB homologs can also control toxin-antitoxin (TA) systems known to modulate bacterial growth in response to stress. In such TA-chaperone (TAC) systems, SecB assists the folding and prevents degradation of the antitoxin, thus facilitating toxin inhibition. Chaperone dependency is conferred by a C-terminal extension in the antitoxin known as chaperone addiction (ChAD) sequence, which makes the antitoxin aggregation-prone and prevents toxin inhibition. Using TAC of Mycobacterium tuberculosis, we present the structure of a SecB-like chaperone bound to its ChAD peptide. We find differences in the binding interfaces when compared to SecB-SecA or SecB-preprotein complexes, and show that the antitoxin can reach a functional form while bound to the chaperone. This work reveals how chaperones can use discrete surface binding regions to accommodate different clients or partners and thereby expand their substrate repertoire and functions.
U niversally conserved molecular chaperone machines maintain cellular protein homeostasis by preventing protein misfolding and aggregation, off-pathways in protein biogenesis. In bacteria, the ATP-independent homotetrameric chaperone SecB (69 kDa) assists protein export by binding to presecretory proteins and delivering them posttranslationally to the Sec translocon at the inner membrane 1 . SecB binds its preprotein clients in a one to one ratio and maintains them in nonnative translocation competent state, protected from premature folding and recognition by cytosolic proteases 2 . Although SecB has no apparent specificity for signal sequences, in vitro peptide scan analysis revealed preferences for stretches of nine amino acids enriched in aromatic and basic residues present in protein clients 3, 4 . SecB can accommodate long fragments of up to 150 amino acids in length within polypeptide substrates 5 . The recently determined nuclear magnetic resonance (NMR) structures of SecB bound to its full-length native substrates maltose-binding protein (MBP) and alkaline phosphatase (PhoA) confirmed that SecB possesses a remarkably large substrate-binding surface (about 7600 Å 2 ) where the client protein wraps all around the chaperone in an unfolded conformation, occupying the entire SecB substrate-binding surface 6 .
In addition to its preprotein clients, SecB specifically interacts with SecA, the essential ATPase motor subunit of the Sec translocon 7 . Upon interaction, SecB passes on its client to SecA, which subsequently promotes preprotein translocation through the SecYEG pore. SecA-SecB interaction mainly involves the Cterminal zinc-binding region of SecA and the negatively charged surface formed by the β-sheets on both sides of the SecB tetramer 8 . However, additional contacts between the C-terminal helix of SecB and the N-terminal region of SecA have been found 9 . Although the substrate transfer mechanism remains unknown, the surfaces of SecB that interact with the preprotein and with SecA overlap significantly, thus likely facilitating substrate transfer from the chaperone to the translocase.
Besides the generic role of SecB in protein export, SecB homologs are frequently associated (in about 7% of cases) with stress-responsive type II toxin-antitoxin (TA) systems, together forming functional tripartite TA-chaperone (TAC) systems 10 . Classical type II TA systems are small genetic modules encoding two cytosolic proteins: a poisonous toxin and a less stable and protease-sensitive cognate antitoxin, which binds and inhibits the toxin. Under normal growth conditions, the antitoxin-bound toxin is inactive and the bacteria grow normally. It is believed that under certain stress conditions the less stable antitoxin is degraded by proteases and that the resulting free active toxin targets essential cellular processes such as protein synthesis or DNA replication, thus inhibiting growth until normal growth conditions resume 11, 12 . TA systems are also widely distributed on mobile genetic elements, including plasmids, where they contribute to their stability. In this case, when the TA-containing plasmid is lost, de novo synthesis of the antitoxin stops and the reservoir of cytosolic antitoxin is rapidly degraded, which results in toxin activation and cell growth inhibition 13 . Control of bacterial growth by toxins has been associated with various cellular processes, including stabilization of genomic regions, protection against foreign DNA, biofilm formation, control of the stress response, bacterial virulence and persistence 14, 15 . Although an involvement of TA systems in persistence was found for several bacteria [16] [17] [18] [19] their contribution to Escherichia coli K-12 drug persisters has not been demonstrated 20, 21 . In tripartite TAC systems, the SecB chaperone encoded within the same operon as the TA genes, directly interacts with the highly unstable TAC antitoxin and prevents its aggregation and degradation, thus facilitating subsequent inhibition of the toxin 22 .
The human pathogen Mycobacterium tuberculosis possesses such a TA-associated SecB chaperone, named Mtb-SecB TA , which specifically controls the Mtb-HigB1 (toxin)-HigA1 (antitoxin) TA pair 12, 22 . Mtb-HigB1, which likely belongs to the RelE toxin superfamily of ribonucleases, was shown to severely inhibit E. coli, M. smegmatis, M. marinum, and M. tuberculosis growth 12 . Noticeably, Mtb-TAC genes were shown to be significantly induced in response to several stresses relevant for M. tuberculosis pathogenesis. This includes DNA damage 23 , heat shock 24 , nutrient starvation 25 , hypoxia 26 , host phagocytes 27 and antibiotic-induced persistence 28 , suggesting that the TAC system could contribute to the stress adaptive response and/or to the virulence of this bacterium. Yet, such a role for TAC remains to be demonstrated.
We have recently shown that in contrast with chaperoneindependent TA systems, the Mtb-HigA1 antitoxin of TAC possesses a C-terminal extension, named ChAD (chaperone addiction), which makes the antitoxin more aggregation-prone and renders it chaperone-dependent. In this case, the ChAD extension is specifically recognized by the Mtb-SecB TA chaperone, which protects it from both aggregation and degradation 29 .
In this work, we provide biochemical and structural insights into the mechanism of chaperone addiction. Using TAC of M. tuberculosis as model system, we solved the crystal structure, at high resolution, of a TA-associated SecB chaperone bound to the ChAD peptide of its cognate antitoxin. The structure reveals major differences in binding mode and substrate occupancy when compared to SecB-SecA or SecB-substrate complexes. Further extensive mutagenesis of contact surface residues revealed several previously unidentified residues essential for TA-control by Mtb-SecB TA chaperone in vivo. Finally, we showed that the antitoxin can reach a functional form while bound to the chaperone and that ChAD peptide may efficiently destabilize the interface between the antitoxin and the chaperone in vitro and specifically activate the Mtb-HigB1 toxin in vivo.
Results
Three-dimensional structure of Mtb-SecB TA in complex with ChAD. In contrast with the classical export chaperone SecB, which binds and wraps unfolded presecretory protein substrates and maintains them in an unfolded conformation compatible with translocation through membrane 6 , previous work revealed that the Mtb-SecB TA chaperone of TAC is capable of binding to its aggregation-prone Mtb-HigA1 antitoxin substrate to facilitate, and thus not prevent, its folding in the cytosolic space. This strongly suggests a different binding mode of SecB-like chaperones with their antitoxin clients. To investigate the SecB substrate-binding property, we have solved the structure of Mtb-SecB TA together with the short C-terminal fragment of the Mtb-HigA1 antitoxin (named ChAD), which was found as the main site of interaction with the chaperone, both in vivo and in vitro 29, 30 . The structure comprises a Mtb-SecB TA homotetramer (the subunits, termed A-D, contain 136-138 residues of the 181 amino acids found in the Mtb-SecB TA sequence) to which three ChAD peptides (corresponding to sequence 104 EVPTWHRLSSYRG 116 of Mtb-HigA1 named C4 in a previous study 29 ; subunits E-G), 2 dimethyl sulfoxide (DMSO) molecules, and 3 Ca 2+ ions are bound ( Table 1 and Fig. 1a ). The Mtb-SecB TA structure resembles that of SecB for which four structures have been solved: the X-ray structures of Haemophilus influenzae SecB alone 31 and in complex with the C-terminal 27 residues of SecA 8 , the X-ray structure of E. coli SecB alone 32 , and the NMR structures of its complexes with alkaline phosphatase and maltose-binding protein in their unfolded states 6 ( Supplementary  Fig. 1a ). The three-dimensional fold of Mtb-SecB TA consists of a six-residue long N-terminal helix (αN) followed by a fourstranded antiparallel β-sheet (β1-β4), each strand contributing 13-16 residues, and a 30-residue long C-terminal helix (α1) that is prolonged by an extended peptide segment running parallel to α1 ( Fig. 1b and Supplementary Fig. 1b ). Missing residues are found in the majority at the N and C termini (5-12 and 15-19 residues missing, respectively) and in the loop between β3 and β4 (13-16 residues missing), in all subunits. The superposition of the subunits making up the Mtb-SecB TA tetramer led to a root mean square deviation (rmsd) of Cα atoms ranging between 0.4 (subunit C vs. B) and 1.2 Å (subunit C vs. A). This is in line with the NMR characterization of SecB, which revealed two pairs of spectroscopically equivalent subunits formed on the one hand by subunits A and D and on the other hand by subunits B and C 6 . Largest deviations correspond to spatial locations lining regions with missing residues, which in turn correlates with high Bfactors, thus indicating structural flexibility.
The Mtb-SecB TA tetramer consists of a dimer of dimers as already described for SecB 31, 32 . Two subunits associate through their β1 strands to form β-dimers (A-B and C-D), resulting in an eight-stranded antiparallel β-sheet ( Fig. 1a ). In the tetramer, the A-B and C-D β-dimers are stacked up through their helices α1 at an angle of ca. 45° (Fig. 1a ). The dimer and dimer-dimer interface areas are in the same range: 739/728 Å 2 for A-B/C-D vs. 820/704 Å 2 for A-C/B-D (Supplementary Table 1 ). It is noteworthy that the tetramer displays internal dihedral (D 2 ) symmetry that includes three perpendicular twofold symmetry axes. However, not all among the three possible superimpositions through rotations around these axes are equivalent. Only one permutation (DCBA) gives a rmsd value of 0.6 Å after superposing 522 Cα atoms to the reference tetramer (ABCD), whereas the two others (BADC and CDAB) led to much higher rmsd values of 3.5 Å. The DCBA permutation is generated through rotation around the twofold axis that lies between the dimer-dimer interface and runs nearly perpendicular to helices α1 (Fig. 1a ). This distorted dihedral symmetry is also found in the previously determined SecB structures (PDB entries 1FX3, 1OZB, 1QYN, and 5JTL), but has never been described before. Molecular dynamics calculations performed on the structure suggest that this distorted arrangement is stable over the 60-ns simulation time, and that once trapped into such a conformation, no further fluctuation does occur ( Supplementary Fig. 2a ).
It has recently been reported that diffraction-quality crystals of Mtb-SecB TA could only be grown at high concentrations of DMSO. Indeed, the use of DMSO improved initial needle-like crystals but was not sufficient to resolve the structure 33 . Adding 5-10% DMSO in the protein and/or crystallization buffer played a role with respect to nucleation but did not markedly influence the diffraction limit of Mtb-SecB TA /ChAD crystals. We also noted that the presence of calcium ions was important for the crystallization of the complex. Three Ca 2+ ions were localized based on electronic density and geometric criteria, and calcium binding occurs in subunits A, B, and D at the same position ( Fig. 1a ). Indeed, all three ions interact with main-chain nitrogen atom and side-chain oxygen atom of S65, with the main-chain oxygen atom of Y111, and with the carboxylate of D110 thereby linking the N-and C-termini of strands β3 and β4, respectively. The lack of calcium binding to subunit C is due to crystal packing constraint where loop β4-α1 of a symmetry mate partly occupies the site.
Comparison of Mtb-SecB TA and SecB structures. Pairwise comparison of the Mtb-SecB TA crystallographic tertiary structure with those of Hi-SecB and Ec-SecB gave rmsd values around 2.0 Å for about 110 Cα atoms of residues sharing 15% identity. In comparison, superimposition of the Hi-and Ec-SecB subunits led to rmsd values less than 1.0 Å for ca. 130 residues sharing 59% identity. There are three major differences between the Mtb-SecB TA tertiary structure and its SecB counterparts ( Fig. 1b and Supplementary Fig. 1b ): (i) Mtb-SecB TA has a longer N terminus that adopts a helical fold (αN), (ii) it has a 12-to 14-residue long insertion in the loop between β3 and β4, which is disordered in the structure, and (iii) its C terminus is shorter and could not be traced beyond residue number 164. In contrast, the C-terminal ends of Hi-and Ec-SecB are better defined in density where they form helix α2. We verified by mass spectrometry (MS) of dissolved crystals that no proteolytic cleavage, which could account for the missing C-terminal residues, had occurred in the crystalline state. Structural dynamics might then be responsible for the absence of electron density for the C-terminal residues of 
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Mtb-SecB TA and the location of a C-terminal α2 helix as found in Hi-and Ec-SecB. Such flexibility might be fostered by the proximal location of the N-terminal helix, whose position is dictated for some of the subunits by crystal packing constraints, and which otherwise would induce steric clashes ( Supplementary Fig. 1b ).
Other differences between the Mtb-SecB TA and SecB structures occur in loops β1-β2, β2-β3, and β4-α1 ( Fig. 1b and Supplementary Fig. 1 ). Superimposing the crystal structure of Mtb-SecB TA tetramer with those of Ec-and Hi-SecB gave rmsd values around 2.0 Å. In comparison, superposing the Ec-and Hi-SecB tetramers led to rmsd values of 0.9 Å. Although the tetramers are highly similar in structure, important variations were found when comparing the dimer and dimer-dimer interface areas (Supplementary Table 1 ). Whether these structural differences are important for TA control, export function or protein stability is unclear. The fact that all the TAC chaperones tested so far could efficiently replace Ec-SecB export function, regardless of the sequence similarities 10, 29 , and that single-point mutations in substrate-binding area were sufficient to redirect Ec-SecB toward Mtb-HigBA1 without affecting its function in protein export 30 , suggest that such differences may not be critical for TA control or export.
Mtb-SecB TA and related Ec-and Hi-SecB are acidic proteins that remarkably share a strictly identical theoretical pI value of 4.3. In accordance, analysis of the topography and charge distribution revealed that they display very electronegative molecular surfaces but differences between the SecB proteins and Mtb-SecB TA are noticeable ( Supplementary Fig. 3 ). Major differences pertain in fact to negative charge distribution. For instance, there is a strong electronegative cluster right in the middle of the SecB eight-stranded β-sheet, which arises from sidechain clustering of residues D20/D27, E24/E31, and E77/E86 (Ec-SecB/Hi-SecB numbering), which is important for interaction with SecA C-terminal region. In Mtb-SecB TA , these residues are replaced by R32, A36, and D102, respectively. The fact that Mtb-SecB TA is less efficient than Ec-SecB when tested for SecAdependent function in E. coli suggests that such modified electrostatic interface might be responsible for the reduced complementation in vivo.
Another important difference is found in a groove delineated by the N-terminus of strand β1, the β1-β2 loop, helix α1, and the extended C-terminal segment. This groove is neutral or slightly positively charged in SecB whereas it is electronegative in Mtb-SecB TA , involving the D27, E143, and D147 residues and the positively charged R151. In contrast, only one acidic residue is found in SecB, E112/E121, which corresponds to E143 of Mtb-SecB TA , and is counterbalanced by R120/R129 equivalent to R151 in Mtb-SecB TA .
Mtb-SecB TA /ChAD interaction. In order to investigate how the chaperone specifically recognizes the C-terminal chaperoneaddiction region of the Mtb-HigA1 antitoxin, key residues involved in the interaction between the ChAD peptide (Mtb-HigA1 104 EVPTWHRLSSYRG 116 ) and the Mtb-SecB TA chaperone substrate-binding surface were analyzed in detail. Note that this small peptide represents the main region of the ChAD extension of Mtb-HigA1 that is recognized by the chaperone, both in vivo and in vitro 29 . In the structure, there are three bound ChAD peptides (chains E-G) per tetramer ( Fig. 2a ). For all three peptides, there was no adequate electron density to build the last residue (G116) and the side chain of R115 is also missing in peptide G ( Supplementary Fig. 4 ). Binding occurs on the thinner side of the Mtb-SecB TA chaperone tetramer. On one side, two peptides (chains E and F) are bound in a symmetrical way (related by a twofold axis) and adopt strictly the same extended conformation with a rmsd of 0.6 Å based on main-chain atoms. The third peptide (chain G) binds on the opposite side and also adopts an extended conformation identical from residues 104-108 (rmsd of 0.5 Å on backbone atoms) but differs in mainchain (φ,ψ) angles from residues 109-114 (rmsd of 2.1 Å). It is noteworthy that peptide G differs in conformation from peptides E and F to conserve the same type of interactions with the protein, and molecular dynamics (MD) calculations indicate that such binding mode is preserved during the 60 ns of simulation ( Supplementary Fig. 2b ). On the other hand, no sufficient interpretable electron density could allow the building of a symmetrical equivalent of peptide G ( Supplementary Fig. 4 ), which because of steric clashes due to the distorted D 2 symmetry would not be possible without structural rearrangement. Each bound peptide makes contact with three protein subunits in a similar way, with some variations (Fig. 1c) . A residue-per-residue detailed description of the interactions is given in Supplementary Table 2 .
In agreement with previous in vivo data 29, 30 , the structure reveals that three ChAD residues play a major structural role in complex formation, namely W108, R110, and Y114. Mtb-HigA1 (W108) makes strong interactions with the protein (Fig. 2b ). It is involved in hydrogen bonding with D27 located on strand β1. In addition, its indol ring is completely buried in a protein cavity delineated by residues D27, R29, V68, and L108, from one Mtb-SecB TA subunit, and A153 (at the C terminus of α1) from another Mtb-SecB TA subunit. It is also involved in cation-π interactions with R29 side chain. Mtb-HigA1(R110) makes strong polar interactions with D27 and I28 from one subunit, and with G150 (at the C terminus of α1) from another subunit ( Fig. 2b ). van der Waals interactions with a third protein subunit also contributes to the steady anchoring of Mtb-HigA1(R110). Mtb-HigA1(Y114) is hydrogen bonded to the protein through interaction with P155. In addition, its phenol group perfectly fits a gorge delineated by residues L47, Y49, L154, P155, P156, and L157 ( Fig. 2c ).
Mutagenesis of Mtb-SecB TA residues involved in ChAD binding. In order to investigate whether the interaction between Mtb-SecB TA and the antitoxin was relevant in vivo, all residues of Mtb-SecB TA involved in polar interactions with the ChAD peptide, either through side-chain or main-chain atoms, and those involved in nonbonding interactions through burying more than 50% of their solvent accessible surface ( Fig. 1b and Supplementary Table 2 ) were systematically mutated to alanine residues. The resulting variants were then tested for both their Fig. 1 Overall structure of the Mtb-SecB TA /ChAD complex and determinants of SecB ligand specificity. a The A-D subunits forming the Mtb-SecB TA tetramer are respectively colored in green, orange, violet, and yellow whereas ChAD peptides (chains E-G) are in slate blue. Calcium ions are shown as green spheres. DMSO molecules (labeled DMS) are shown as a stick representation. Left and right views are separated by a 90°rotation around a vertical axis. Secondary structures have been labeled for the A-B (left) and A-C (right) dimers. b Structure-based sequence alignment. Sequence similarity is indicated by red letters, whereas sequence identity is indicated by white letters on a red background. Aligned and unaligned residues are displayed in uppercase and lowercase, respectively, taking Mtb-SecB TA as reference. Secondary structure elements as deduced from the crystal structures of Mtb-SecB TA /ChAD, Ec-SecB (PDB code 1QYN), and Hi-SecB (1FX3) are indicated. Residues absent from the structures are on a green background. Residues involved in protein-protein interface of the Mtb-SecB TA /ChAD, Ec-SecB/PhoA (5JTL), and Hi-SecB/SecAc (1OZB) complexes are indicated by symbols: solid ellipses and triangles, residues involved in polar interactions through side-chain and main-chain atoms, respectively; stars, residues having ≥50% of their surface area buried upon van der Waals interactions. For Mtb-SecB TA , color coding of the symbols is according to the impact of alanine scanning on the ability to maintain TA control from green (no effect) to orange (medium effect) to red (most severe effect). Residues that were not tested (i.e., Ala residues and Y146, which was too strongly expressed) are designated by unfilled symbols. The V40A/L42A/L44A triple substitution that causes a 40-fold reduction in the affinity of Ec-SecB for PhoA is in purple. c Sequence of the Mtb-HigA1 ChAD peptide. The rectangles below the sequence represent the amino acids that have been changed for alanine as previously reported 29 . Green rectangles represent mutations without apparent phenotype with respect to their chaperone dependence in vivo; orange, mutations with partial inactivation; red rectangles, mutations with the most severe phenotype. Interfacing residues with Mtb-SecB TA are depicted using the same symbol scheme as in a Color coding of interacting residues is the same as in Fig. 1b ability to control the toxin ( Fig. 3 ) and to functionally replace the canonical E. coli export chaperone SecB with respect to its generic chaperone function at low temperature and in the presence of novobiocin antibiotic 34, 35 (Supplementary Fig. 5 ). Steady state expression of the Mtb-SecB TA derivatives revealed that all mutants are well expressed when compared to the wild type ( Supplementary Fig. 6 ). Mtb-SecB TA mutations that most significantly affect TA control were found at positions making strong interactions with ChAD residues shown to be involved in chaperone binding 29 , namely residues D27, R29, and L108 interacting with Mtb-HigA1(W108), and residues Y49, I77, L154, P155, P156, L157 interacting with Mtb-HigA1(Y114) (Fig. 2b, c) . 
It is noteworthy that Mtb-HigA1(G116), whose mutation to alanine was also associated to a defect in vivo 29 , could not be resolved in the electron density. Moreover, residues D27 and L154 of Mtb-SecB TA are also involved in interactions with R110 of Mtb-HigA1 (Fig. 2b) . Two other Mtb-SecB TA residues, L47 and F67, appeared to be important in vivo. Although not directly interacting with Mtb-HigA1(Y114), L47 contributes to the pocket that accommodates the tyrosine phenol ring (Fig. 2c ). The role played by F67 seems to be more structural since the phenylalanine ring is oriented toward the interior of the protein thereby contributing to a network of hydrophobic/aromatic interactions. The mutation for an alanine might locally destabilize the protein hydrophobic core and in turn the positioning of strand β3 backbone, which is involved in ChAD interaction. Noticeably, although spread all over the sequence, essential residues of Mtb-SecB TA involved in the interaction with ChAD define two major binding spots when mapped on the 3D structure (Fig. 1 ). The first spot is located on the β-sheet of one of the four tetramer subunits, and involves strands β1-β3. The second spot, which comprises the residues most severely affected by mutations, is found on the protomer of the adjacent β-dimer. It involves the N-terminal tip of strand β2 and residues that follow helix α1 and form the helix connecting loop. Such crosslinking of ChAD peptides at the surface of the Mtb-SecB TA tetramer might tighten, or even lock, the dimer-dimer interface and explain the improvement found in both diffraction quality and resolution of the crystals of the Mtb-SecB TA /ChAD complex vs. those of Mtb-SecB TA .
All the Mtb-SecB TA mutations that most significantly impaired TA control additionally affected the ability to replace the E. coli export chaperone SecB in vivo at low temperature of growth, with the exception of Y49A ( Supplementary Fig. 5 ). Remarkably, Y49A significantly improved Mtb-SecB TA ability to replace Ec-SecB in vivo. Two other mutations, G46A and D58A, slightly improved Mtb-SecB TA chaperone generic function but, in contrast with Y49A, without affecting TA control. These three residues are spread along strand β2, G46, and Y49 close to each other at the N-terminal side and D58 at the C terminus. It is noteworthy that Mtb-SecB TA (Y49) corresponds to Ec-SecB(V40) whose mutation as part of the triple amino-acid substitution V40A/L42A/L44A (with all three residues on β2) was shown to cause a 40-fold reduction in the affinity of Ec-SecB for PhoA 6 . Whether these mutations affect SecB substrate-binding specificity or its interaction with its SecA partner is not known.
Specific affinity of ChAD for Mtb-SecB TA chaperone. Several approaches were used to characterize complex formation between Mtb-SecB TA and the ChAD peptide in solution and to further confirm structure-function relationships deduced from the X-ray structure and mutagenesis experiments. Isothermal titration calorimetry (ITC), performed under both direct and reverse conditions, and microscale thermophoresis (MST) showed that the chaperone interacts with the ChAD peptide with moderate affinity, with a K d dissociation constant of 1.9 ± 0.2 and 2.6 ± 0.6 µM, respectively (Fig. 4a, b) . The ITC-derived thermodynamic parameters indicated an enthalpy-driven mode (−50.1 kJ mol −1 ) accompanied with an entropic penalty (−TΔS = 18.7 kJ mol −1 ), likely suggesting formation of hydrogen bonds associated with binding, which is in line with the crystal structure. On the other hand, the stoichiometry obtained by direct and reverse ITC for this specific association is 0.47 and 2.2, respectively, consistent with a model preferentially involving two peptides per Mtb-SecB TA tetramer. Extensive small-angle X-ray scattering (SAXS) analysis performed on different protein preparations systematically revealed that the scattering curves corresponding to Mtb-SecB TA and Mtb-SecB TA /ChAD peptide displayed small but significant differences (Fig. 4c ). Both Guinier and the concentration-independent method 36 were applied to SAXS data and gave respective molecular weight of 84.5 ± 0.1, 81.7 ± 0.4 kDa for Mtb-SecB TA and 89.7 ± 0.1, 83.6 ± 0.3 kDa for Mtb-SecB TA / ChAD. The chaperone alone and its complex with ChAD form well folded molecular species, as can be observed from normalized Kratky plots (Fig. 4c, inset) , and Guinier analysis gave R g values of 3.17 ± 0.02 and 3.02 ± 0.02 nm and maximum dimensions of the particles (Dmax) of 9.5 ± 0.2 and 8.8 ± 0.2 nm, respectively. This indicates that, at the resolution probed, Mtb-SecB TA does not undergo a major conformational change upon ChAD peptide binding but rather displays a slight compaction and a less dynamic behavior. These properties might be related to the better diffracting quality of the crystals obtained in the presence of the peptide. In addition, the scattering curve calculated from the Mtb-SecB TA /ChAD peptide crystal structure, where the missing loops representing 24% of the unbuilt residues have been modeled, led to a rather good, albeit not perfect, agreement (χ = 2.6) with experimental data (Fig. 4c ). To further investigate the dynamic behavior of the chaperone, we performed Hydrogen-Deuterium eXchange MS (HDX-MS) on Mtb-SecB TA alone and in the presence of ChAD peptide. The kinetics of exchange for Mtb-SecB TA alone revealed some highly dynamic and/or accessible regions (namely residues 13-18, 37-51, 59-67, and 161-181, in line with the absence of electron density for the C-terminal residues of Mtb-SecB TA ) compared to more protected regions (residues 68-75, 98-108, and 124-152). Interestingly, a large decrease in deuteration upon binding of the ChAD peptide was observed for residues 21-27 and 153-159, which are precisely located along the peptidebinding pocket, and juxtaposing residues 52-57 ( Supplementary  Fig. 7a ). These results also confirm that the chaperone is rather stable upon complex formation with ChAD.
The deconvoluted MS spectrum obtained for Mtb-SecB TA under nondenaturing conditions clearly showed the presence of a tetramer at 81,575 Da and up to 7 additional species, separated by 1587 Da, progressively appearing upon titration with the ChAD peptide ( Fig. 4d and Supplementary Fig. 8a ). Binding of the first four peptides to the tetrameric chaperone corresponds to relatively highaffinity events, as they occur at small peptide:tetramer ratios (<4), whereas binding of the three additional peptides only occurred at high molar ratios (>4), probably due to nonspecific interactions ( Supplementary Fig. 8a ). Plotting the relative abundance obtained for each species at increasing molar ratios and fitting the corresponding curves ( Supplementary Fig. 8b ) confirmed this observation, with K d values in the range 6-17 µM. Incubation of the chaperone with 8 molar equivalents of 13-mer peptides, which also belong to the ChAD sequence but do not contain the main chaperone-binding determinants 29 , only showed limited binding to the tetramer, confirming the higher binding specificity observed for the ChAD peptide (Fig. 4e) . This low-abundance interaction may be related to some non-specific binding also observed at high molar ratios of ChAD peptide. The nonspecific adduction is a common feature of native MS when working with substrate/ligand concentrations greater than 50 µM 37 .
Full-length Mtb-SecB TA /HigA1 chaperone/antitoxin complex. Multiple attempts to crystallize the full-length Mtb-SecB TA / HigA1 complex were unsuccessful, although such complex could be easily purified in a stable soluble form. Size exclusion chromatography and multi-angle light scattering (SEC-MALS) clearly indicated that Mtb-SecB TA alone primarily forms tetramers while experiments performed on Mtb-SecB TA co-expressed with Mtb-HigA1 revealed a single-molecular species representing a 4:2 chaperone/antitoxin stoichiometry (Fig. 5a) . These results were further confirmed by native MS (114.9 kDa, see next paragraph).
In addition, we found that under the same experimental in vitro condition, purified Mtb-HigA1 ΔC42 mutant, which was shown to be fully soluble and functional in vivo in the absence of chaperone 29 , was isolated as a dimer (Fig. 5a ), as observed with known chaperone-independent HigA antitoxins 38, 39 . SAXS was also used to characterize full-length Mtb-SecB TA /HigA1. The corresponding scattering curve is significantly distinct from those obtained for Mtb-SecB TA alone or in complex with the peptide and reflects a well folded protein/protein complex (Fig. 4c ) of molecular weight 114.4 ± 0.1 and 120.0 ± 0.3 kDa as obtained from Guinier and concentration-independent methods, respectively, and with R g and Dmax values of respectively 3.61 ± 0.02 and 12.0 ± 0.2 nm. Finally, we performed HDX-MS on the Mtb-SecB TA /HigA1 complex. Strikingly, binding of the chaperone to Mtb-HigA1 client resulted in the protection of the same stretches of residues as for Mtb-SecB TA /ChAD with the addition of residues 48-51 and 59-66, which are located in the continuity of the peptidebinding pocket ( Supplementary Fig. 7b ). This observation suggests a significantly larger binding interface between the chaperone and full-length Mtb-HigA1 when compared to the short ChAD peptide. We also did not find any specific destabilization of Mtb-SecB TA upon complex formation with Mtb-HigA1, which is in agreement with the Kratky analysis of the SAXS data.
As observed for most type II DNA binding antitoxins, Mtb-HigA1 can act as a repressor of its own Mtb-higBA1 operon 40 . In order to further investigate the activity of soluble dimeric Mtb-HigA1 bound to Mtb-SecB TA tetramers, we have used SEC-MALS, native MS, and ITC to monitor the interaction between the purified Mtb-SecB TA /HigA1 complex and dsDNA using a 38bp palindromic sequence derived from the higB P2 promoter. ARTICLE demonstrated that Mtb-SecB TA /HigA1 forms a single stable molecular species in the presence of DNA, most likely corresponding to 4:2:1 Mtb-SecB TA /HigA1/DNA stoichiometry (Fig. 5a) , with a shift in the hydrodynamic radius from 4.4 to 5.0 nm upon DNA binding. We verified by SEC-MALS that no interaction occurs between Mtb-SecB TA /HigA1 and a nonspecific dsDNA such as a 16-bp oligonucleotide derived from the RRM1 promoter 41 . We also used native MS to analyze Mtb-SecB TA / HigA1 in complex with its specific DNA target and observed that they indeed form a 4:2:1 complex of molecular weight 138.25 kDa ( Supplementary Fig. 9a ). In addition, ITC experiments showed that the higB P2 promoter DNA fragment interacts with the hexamer with a high affinity (2.2 ± 0.5 × 10 7 M −1 at 25°C) (Fig. 5b) . The ITC-derived thermodynamic parameters indicated an enthalpically and entropically favored binding (ΔH = −26.1 kJ mol −1 and −TΔS = −15.9 kJ mol −1 ) suggesting association to the major groove of DNA 42 . The stoichiometry obtained by ITC for this specific association is 1.1, consistent with a binding involving one palindromic DNA sequence per Mtb-HigA1 dimer present in the Mtb-SecB TA /HigA1 hetero-hexamer. Measuring the temperature dependence of the enthalpy gave a negative heat capacity of binding (−1.3 kJ mol −1 K −1 ) as typically reported for the majority of sequence-specific protein/DNA associations 43 .
Together these results show that the highly unstable Mtb-HigA1 antitoxin can form a functional dimer following binding to its specific chaperone partner. It has been proposed that disrupting the TA interfaces by small molecules or peptides to trigger endogenous toxin activation in vivo could represent a novel antibacterial tool to induce bacterial death from the inside 44 . The tripartite TAC system significantly differs from classical two-component TA systems due to the fact that the TAC antitoxin has acquired a C-terminal ChAD segment, which efficiently triggers antitoxin aggregation and/or degradation in the absence of chaperone, thus leading to toxin activation. Therefore, we hypothesized that disrupting an earlier step in the toxin inactivation pathway, namely the interaction between the chaperone and its antitoxin client, might lead to growth inhibition. To begin to approach this specific point, we first used native MS experiments to investigate whether a stably formed Mtb-SecB TA /HigA1 complex could be disrupted in vitro by increasing concentrations of ChAD peptide. In the absence of peptide, we mainly found 4:2 Mtb-SecB TA /HigA1 hetero-hexamers together with Mtb-SecB TA tetramers, with MW of 114.9 and 81.6 kDa, respectively ( Supplementary Fig. 9b ). Upon incubation with low amounts of ChAD, we observed peptide binding to both tetrameric Mtb-SecB TA (as described above) and to the Mtb-SecB TA /HigA1 hexamer ( Supplementary  Fig. 9c, d) . At higher peptide concentrations, more ChAD peptides bound to the hexamer, leading to the progressive dissociation of the tetramer from the complex ( Fig. 5c and Supplementary Fig. 9e, f) . These results suggest that a preformed antitoxin/chaperone complex in vivo might also be disrupted by the presence of a ChAD competitor, thus leading to a free active toxin and the subsequent inhibition of bacterial growth. To test such a hypothesis, we constructed luciferase chimeras containing a grafted C-terminal ChAD extension, either wild type or carrying the Y114A mutant unable to interact with the chaperone, overexpressed them in the presence of TAC and monitored bacterial growth in our toxicity rescue assay (Fig. 5d ). Remarkably, we found that expression of the luciferase chimera with wild-type ChAD sequence could severely inhibit bacterial growth in the presence of TAC, while the Y114A mutant or the luciferase without ChAD could not. Together these results suggest that Mtb-SecB TA /HigA1 complexes, with or without Mtb-HigB1 toxin, can be disrupted both in vitro and in vivo.
Discussion
In this work, we provide biophysical and structural insights into the mechanism of chaperone addiction. We solved the highresolution crystal structure of a TA-associated chaperone bound to the ChAD region of its antitoxin client. This structure reveals major differences in binding mode when compared to SecB-SecA or SecB-presecretory substrate complexes ( Fig. 6 ) and identifies major contact surface residues involved in the chaperone-antitoxin interface.
The first structural report of a complex between SecB and a partner protein was the 2.8 Å X-ray structure of Hi-SecB with the C-terminal 27 residues of SecA (SecAc) 8 . In this structure, SecAc adopts a totally different conformation than the one adopted by the Mtb-HigA1 (104-116) region and binding to the Hi-SecB chaperone occurs at a very different position with respect to the tetramer ( Fig. 6 and Supplementary Fig. 1a ). In this case, there are two bound SecAc peptides per Hi-SecB tetramer and each peptide interacts with the acidic cluster found on the eight-stranded βsheet, resulting in a predominantly electrostatic interface 8 ( Fig. 1b and Supplementary Fig. 3 ). More recently, a comprehensive NMR analysis of the interaction between Ec-SecB and two different secretory protein clients (namely PhoA and MBP) in the unfolded state has been published 6 . The solution structure of the different complexes shows how a single-protein client wraps around the Ec-SecB tetrameric assembly and is in agreement with earlier biochemical data showing that Ec-SecB can interact with long stretches of unfolded protein substrates 5, 45 . Here, we mainly refer to the Ec-SecB-PhoA complex, which was the most thoroughly analyzed in the NMR study ( Supplementary Fig. 1a ). In this case, the client protein interacts through long unstructured hydrophobic segments that mostly fill the chaperone hydrophobic grooves ( Fig. 1b and Supplementary Fig. 3 ). Remarkably, our data show that binding of PhoA precursor to Ec-SecB shares no apparent similarity with binding of ChAD to Mtb-SecB TA . Indeed, we found that the ChAD peptide binding sites on Mtb-SecB TA run perpendicular with respect to the different PhoA binding sites in Ec-SecB ( Supplementary Fig. 10 ) and that only few residues of Ec-SecB that interact with PhoA have counterparts in Mtb-SecB TA that interact with ChAD. Finally, although some of these residues of the contact surface spatially overlap, the interaction modes are significantly different (Fig. 1b) . This is especially true for the three W108, R110, and Y114 residues of ChAD that are involved in strong interactions with Mtb-SecB TA ( Supplementary Fig. 11 ).
Analysis of the full-length Mtb-SecB TA /HigA1 complex shows that the aggregation-prone antitoxin of TAC forms a dimer when bound to the Mtb-SecB TA chaperone. The dimeric nature of the chaperone-bound antitoxin is in agreement with the observation that the chaperone-independent Mtb-HigA1 deleted of its Cterminal ChAD region (Mtb-HigA1 ΔC42 ) also forms a soluble dimer and is functional in vivo in the absence of the chaperone (this work and ref. 29 ). Such data strongly suggest that the chaperone-bound antitoxin dimer could reach a functional form. This is further supported by the fact that chaperone-bound Mtb-HigA1 has the ability to bind to its native promoter region in vitro and to inhibit the toxin in vivo. Whether such a conformation represents the fully folded antitoxin remains to be determined. Although SecB chaperones mainly assist protein export by preventing the folding of presecretory protein clients, our data show that some SecB chaperones can also assist the folding of cytosolic substrates such as the Mtb-HigA1 antitoxin. This property is in agreement with the observation that overexpressed Ec-SecB can partially rescue the bacterial growth defect of an E. coli strain lacking both major cytosolic chaperones DnaK and Trigger Factor, and that Ec-SecB can bind cytosolic proteins co-and/or post-translationally in vitro 46 .
Our data also reveal that Mtb-SecB TA can potentially accommodate four ChAD peptides, although in this work we show that only one Mtb-HigA1 dimer is bound to one Mtb-SecB TA tetramer. Yet, the full-length ChAD region of Mtb-HigA1 contains a second stretch of residues ( 137 WARHISVR 144 ) that is similar to the first motif ( 108 WHRLSSYR 115 ) present in the ChAD peptide used in this work. Since these motifs resemble the previously identified SecB-binding motifs 4 , that they both contain at least the key tryptophan and arginine residues involved in tight interaction with the chaperone, and that they are separated by a stretch of 21 amino-acid residues, such additional segment might well contribute to a secondary, lower affinity binding site. Note that in this case, binding would require a structural rearrangement at the chaperone level to unlock steric constraints due to its distorted dihedral symmetry. In addition, secondary binding events could further increase the affinity of the antitoxin for the chaperone, when compared to the peptide alone. On the other hand, these two binding sites might stay readily accessible to other substrates or partners, including SecA or presecretory proteins, suggesting that they could also contribute to the activation cycle of the TAC system in response to certain stress, as previously proposed 1 .
Methods
Bacterial strains and culture conditions. E. coli strains W3110 and W3110 secB:: Cm R35 have been described. Bacteria were routinely grown in LB medium supplemented when necessary with kanamycin (50 µg ml −1 ), chloramphenicol (15 µg ml −1 ), or ampicillin (50 µg ml −1 ). For strain W3110 ΔaraBAD::P Tet -Rv1957 (Kan R ) ΔsecB, named WPtet57, the chromosomal araBAD operon was replaced by a cassette containing the Mtb-SecB TA under the control of an anhydrotetracycline inducible promoter using recombineering technology 47 .
Plasmid constructs. Plasmids pMPMK6 48 , p29SEN 49 , p29-Mtb-SecB TA30 , pET-Duet-6HIS Mtb-SecB TA -HigA1, pET15b-Mtb-SecB TA and pK6-Mtb-HigBA1 22 , and pET15b (Novagen) have been described. The p29-Mtb-SecB TA mutant derivatives were constructed by QuickChange mutagenesis (Stratagene) using appropriate primers ( Supplementary Table 3 ) and p29-Mtb-SecB TA as DNA template. The constructs were sequenced verified using appropriate primers. To construct pET15b-Mtb-HigA1 ΔC42 , Mtb-higA1 ΔC42 was PCR amplified with primers pBAD FOR(5′-CGCAACTCTCTACTGTTTC-3′) and higA ΔC42 REV H/B (5′-TTTAA GCTTGGATCCTCACGTAGGCACTTCGCGAAGCGTG-3′) and cloned as a NdeI-BamHI fragment into pET15b vector. To construct plasmids pSE-Luc and pSE-Luc-Mtb-ChAD, the EcoRI/HindIII digested fragments containing the Photinus pyralis luciferase gene, either WT or fused to the Mtb-HigA1 (ChAD) Cterminal region 22 , were subcloned into EcoRI/HindIII digested pSE380ΔNcoI 49 . Plasmid pSE-Luc-Mtb-ChAD was used as template to construct plasmid pSE-Luc-Mtb-ChAD Y114A by QuickChange mutagenesis with higA1 ChAD codon change TAT→GCC. To construct plasmid pC6-Mtb-higBA1, the EcoRV-SphI digested Mtb-higBA1 fragment from pK6-Mtb-higBA1 was cloned into the chloramphenicol resistant plasmid pBAD33 50 digested with the same enzymes.
In vivo TA control by chaperones. Toxin inhibition assay in vivo was performed as described 22 , except that Mtb-SecB TA and its mutant derivatives were cloned on the low-copy plasmid p29SEN 49 . Briefly, fresh transformants of E. coli strains coexpressing the p29SEN-based chaperone and the pMPMK6-based Mtb-HigBA1 pair under the control of the P trc and P BAD promoter, respectively, were grown in LB ampicillin kanamycin to mid-log phase, serially diluted and spotted on LB ampicillin kanamycin agar plates with or without IPTG (to induce the chaperone) and arabinose (to induce Mtb-HigBA1) as indicated in the figure legends. Plates were incubated overnight at 37°C. When strain WPtet57 was used, 4 nM of anhydrotetracycline was added to induce expression of Mtb-SecB TA .
In vivo chaperone assays. It was previously shown that E. coli secB mutants do not grow at low temperature and are sensitive to novobiocin antibiotic 30, 34, 35 , likely due to the intrinsic cold sensitive property of the Sec translocon and to an impaired outer membrane 1, 51 . In this case, it was found that growth at low temperature and resistance to novobiocin requires a functional interaction between SecB and SecA in vivo 30, 35 . Complementation of SecB chaperone activity in vivo at 18°C was performed as follows. Fresh transformants of W3110 ΔsecB::CmR containing p29-Mtb-SecB TA or its mutant derivatives were grown at 37°C to mid-log phase in LB ampicillin, serially diluted, and spotted on LB ampicillin agar plates in the absence or presence of IPTG inducer. Plates were incubated at 37°C overnight or for 3 days at 18°C. For novobiocin resistance, mid-log phase cultures of strain W3110 ΔsecB containing p29-Mtb-SecB TA or its mutant derivatives in LB ampicillin were serially diluted and spotted on LB ampicillin agar plate with 30 µg ml −1 novobiocin, and incubated overnight at 37°C.
Protein purification. Mtb-SecB TA with a N-terminal His 6 -tag was purified following overexpression in a BL21(λDE3) E. coli strain harboring plasmid pET15b-Rv1957 as described 22 . The Mtb-SecB TA /HigA1 complex was overexpressed from plasmid pDUET-1 transformed in BL21(λDE3) giving his-tagged Mtb-SecB TA and untagged HigA1. For production, cells (500 ml) were grown at 30°C to an OD 600 of 0.5 in LB medium containing 100 µg ml −1 ampicillin, and expression of the protein or the complex was induced with 1 mM IPTG for 3 h. Cells were harvested, washed a SecB displays robust antifolding activity when bound to presecretory protein clients as illustrated by the Ec-SecB/PhoA structure, b SecB binds to its SecA partner to perform protein export as illustrated by the Hi-SecB/SecAc structure, and c SecB associated with TA systems binds to the chaperone addiction region of the antitoxin (ChAD), facilitating its folding and subsequent toxin inhibition. The oligomeric states of the different proteins are indicated in parentheses in phosphate-buffered saline (PBS) buffer (pH 7.2), and stored at −80°C. Cells were thawed in lysis buffer (20 mM Tris, 2 mM EDTA, 2 mM DTT, 20 mM imidazole, 100 mM NaCl, pH 7.5) containing 0.5 mg ml −1 lysozyme, sonicated on ice using five intermittent pulses of 30 s, and centrifuged at 30,000 g for 45 min at 4°C. The supernatant was loaded onto a 1-ml HiTrap HP (GE Healthcare) FPLC column, pre-equilibrated in buffer A (20 mM Tris, 0.1 mM EDTA, 200 mM NaCl, pH 7.5) supplemented with 20 mM imidazole. The column was washed with buffer A supplemented with 40 mM imidazole. Elution was achieved with buffer A supplemented with 160 mM imidazole and the more concentrated fractions were pooled. The pooled fractions containing Mtb-SecB TA (approximately 20 mg) or Mtb-SecB TA /HigA1 (approximately 10 mg) were applied onto a HiLoad 16/60 Superdex 200 prep-grade column (GE Healthcare) pre-equilibrated with buffer GF (20 mM MES, 200 mM NaCl, pH 6.5). Mtb-SecB TA eluted as two major peaks characterized as octamer and tetramer using SEC-MALS experiments. Only the fractions corresponding to the tetramer, which eluted at a volume of 72.5 ml, were pooled and subjected to thrombin cleavage to remove the N-terminal His 6 -tag. Mtb-SecB TA /HigA1 eluted as a major peak at 68.2 ml, which was further characterized as a hetero-hexamer by SEC-MALS. Removal of the N-terminal His 6 -tag on Mtb-SecB TA was performed by incubating the protein at 0.5 mg ml −1 in GF buffer with thrombin under shaking for 3 h at room temperature. After checking by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), the cleaved sample was loaded on a HiTrap HP column pre-equilibrated in buffer A supplemented with 20 mM imidazole to remove the tagged protein. Further purification by gel filtration in the conditions described above led to a single peak. Finally, gel filtrated proteins were concentrated with Vivaspin 20 (10 kDa and 30 kDa cutoff for Mtb-SecB TA and Mtb-SecB TA /HigA1, respectively) and either freshly used, for crystallization, or flash-frozen in liquid nitrogen and stored at −20°C while awaiting biophysical characterization.
Mtb-HigA1 ΔC42 (Mtb-HigA1 deleted of the last 42 residues) was overexpressed from pET15b-HigA1 ΔC42 in BL21(λDE3) as a fusion protein containing a Nterminal His 6 -tag. For production, cells (2 l) were grown to an OD 600 of 0.6-0.7 in LB medium containing 100 µg ml −1 ampicillin at 30°C, and expression of the Mtb-HigA1 ΔC42 was induced with 1 mM IPTG for 4 h. Cells were harvested, washed in PBS buffer (pH 7.2), and stored at −80°C. It is noteworthy that all buffers used for purification of Mtb-HigA1 ΔC42 contained 0.2 mM AEBSF. Cells were thawed in lysis buffer containing lysozyme at 0.5 mg ml −1 , sonicated on ice using five intermittent pulses of 30 s, and centrifuged at 30,000 g for 45 min at 4°C. The supernatant was loaded onto a 1-ml HiTrap HP (GE Healthcare) FPLC column pre-equilibrated in buffer A supplemented with 20 mM imidazole. Washing and elution of the column were achieved with buffer A supplemented with 40 and 300 mM imidazole, respectively. Mtb-HigA1 ΔC42 -containing fractions were pooled and concentrated on a Vivaspin 20 (10 kDa) and the recovered retentate applied onto a Superdex 75 10/300 GL column (GE Healthcare) pre-equilibrated with buffer GF. Fractions containing Mtb-HigA1 ΔC42 appeared as a continuous elution (ranging from 11 to 27 ml) confirmed using SDS-PAGE gel. Eluted fractions were pooled, concentrated, flash-frozen and stored at −20°C while awaiting biophysical characterization.
Concentrations were determined by measuring UV absorption at 280 nm with a NanoDrop 2000 spectrophotometer (ThermoScientific) and using calculated molar extinction coefficients (in M −1 cm −1 ) of 15,930 for untagged Mtb-SecB TA (20, 388 Da) , 94,460 for untagged Mtb-SecB TA /HigA1 (considered as a hetero-hexamer of 115,068 Da in all calculations), and 2980 for tagged Mtb-HigA1 ΔC42 (13,997 Da).
Crystallization and structure determination. The 13-mer ChAD peptide corresponding to residues 104 EVPTWHRLSSYRG 116 of Mtb-HigA1 was synthesized by Schafer-N (Copenhagen, Denmark) to >95% purity and solubilized in GF buffer. Purified Mtb-SecB TA was concentrated to 30 mg ml −1 (1.5 mM) in GF buffer and mixtures of Mtb-SecB TA and ChAD peptide, supplemented or not with 5% of glycerol, were subjected to crystallization trials performed at 285 K using the vapor diffusion method in sitting drops. Final peptide concentrations were chosen to reach a peptide/protein molar ratio of 3.0 starting from Mtb-SecB TA protein and ChAD peptide (MW = 1588 Da and calculated molar extinction coefficient of 6990 M −1 cm −1 ) stock solutions at 1.5 and 18.5 mM, respectively. Drops consisting of 200 nL of complex and 200 nL of precipitant solution were equilibrated against 80 µL of reservoir solution. Several crystallization conditions were obtained in the presence of PEG of various molecular weights and additives such as calcium acetate, MgCl 2 , or LiCl. The best diffracting crystals were grown with the protein in GF buffer supplemented with 5% glycerol and in the presence of 100 mM Tris, 25-27% PEG 1500, 80-240 mM calcium acetate, 10% DMSO, pH 8.0. They were directly frozen under a cryogenic nitrogen stream and stored in liquid nitrogen before data collection at 100 K. Diffraction data were measured from tetragonal crystals diffracting to ca. 1.8 Å at the ESRF synchrotron (Grenoble, France) on beamline ID29 using a PILATUS 6M detector. X-ray images were indexed, integrated and scaled on-line using autoP-ROC 52 . Programs from the CCP4 software suite 53 were used for subsequent crystallographic calculations 54 . The structure was determined by the molecular replacement method with PHASER 55 and a starting model derived from the structure of SecB from H. influenzae 31 (PDB code 1FX3 ). An initial model was automatically built with Buccaneer 56 and used as a starting point for iterative refinement with Refmac 57 and manual rebuilding using Coot 58 . Final refinement led to R work /R free values of 0.212/0.265. Data collection and refinement statistics are given in Table 1 .
Quality of the structure was validated during the PDB deposition process. Protein structure databases were searched and structures were superimposed with Dali software 59, 60 and SUPERPOSE from the CCP4 software package. Molecular interfaces were explored using PISA calculations as implemented on the EMBL-EBI server 61 . All structures and the electrostatic potential of protein surfaces were visualized with PyMOL 62 . The sequence alignment was generated with ESPript 3 63 .
MD calculations. The X-ray structure was used to generate a starting template of the Mtb-SecB TA /ChAD complex after building missing residues of the chaperone (Table 1) , finally accounting for 161 residues from Asp6 to Met166. The tleap module of Amber14 64 was used to generate a periodic octahedral box containing the complex extended by 10 Å and filled with TIP3P water molecules and sodium ions to neutralize the overall charge of the system. Energy minimization and MD simulation were performed with the parallel version of the pmemd module of Amber14. After an initial energy minimization with progressively reduced restraints on the position of all atoms (excluding solvent), 100 ps MD were run with temperature varying linearly from 0 to 300 K at constant volume, followed by a 400 ps MD at 300 K and a constant pressure of 1 bar, with the atomic coordinates saved every 2 ps. Three MD simulations of 20 ns were performed at a constant pressure of 1 bar, with atomic coordinates saved every 10 ps. The corresponding trajectories were concatenated in order to build a 60 ns MD simulation. Distance and angle variations in the course of the simulation were analyzed with the cpptraj module 65 from Amber14.
Size-exclusion chromatography and multi-angle light scattering. Samples of Mtb-SecB TA at 49.1 µM (1.0 mg ml −1 ), Mtb-SecB TA /HigA1 at 6.5 µM (0.75 mg ml −1 ), and Mtb-HigA1 ΔC42 at 100 µM (1.4 mg ml −1 ) in 20 mM MES, 200 mM NaCl, pH 6.5 were analyzed on a Superdex 200 Increase 5/150 (GE Healthcare) with multi-angle light scattering. The column was equilibrated with the same buffer, previously sterilized on a 0.1-µm filter, on an Agilent 1260 Infinity LC chromatographic system (Agilent Technology). Data were collected on a DAWN HELEOS-II 8-angle and Optilab T-rEX refractive index detector (Wyatt Technology, Toulouse, France). We loaded 75-100 μl of each protein sample and separation was performed at a flow rate of 0.4 ml min −1 at 15°C. Results were analyzed with ASTRA 6.0.2.9 software (Wyatt Technology Corp.). SAXS experiments. SAXS experiments were conducted in HPLC mode on the BM29 beamline at the ESRF synchrotron, Grenoble, France. Mtb-SecB TA (40 µl at 474 µM and 50 µl at 879 µM), Mtb-SecB TA /HigA1 (60 µl at 136.5 µM) samples in 20 mM MES, 200 mM NaCl, pH 6.5 were injected onto a Superdex 200 Increase 5/ 150 column, equilibrated with the same buffer supplemented with 2 mM DTT, and run at 0.3 ml min −1 and a temperature of 15°C. Mtb-SecB TA was also measured in the presence of the ChAD peptide at a protein:peptide molar ratio of 6:4 (50 µl at 881 µM protein and 588 µM peptide) and the column was equilibrated in the same buffer supplemented with 200 µM of ChAD peptide. Data were collected in a Q range of 0.035-4.9 nm −1 , where Q = 4πsinθ/λ, with a scattering angle of 2θ. A total of 780 frames of 1 ms each were collected throughout the whole elution time. Data, displayed on an absolute scale using water calibration, were processed with the ATSAS suite 66 . After buffer subtraction, Guinier analysis at low Q was performed on each curve using the PRIMUS program to check for the stability of the associated radius of gyration, and the selected frames were averaged. Molecular weights were determined using the concentration-independent method 36 and Guinier analysis using PRIMUS within the limit Q.R g < 1. Regularized indirect transforms of the scattering data were performed with the program GNOM to obtain P(r) functions of interatomic distances.
Microscale thermophoresis. MST assays were carried out on a NanoTemper Monolith NT.115 instrument (NanoTemper Technologies GmbH, Germany). Briefly, Mtb-SecB TA at a concentration of 7.5 µM was labeled with the RED fluorescence dye NT-647 according to manufacturer's protocol in 20 mM MES, 200 mM NaCl, 5% DMSO, pH 6.5. Labeling and removal of free dye were performed within 45 min. Subsequently, 100 nM of NT-647-labeled protein was mixed with various concentrations of ChAD peptide (3 nM to 100 µM) in 20 mM MES, 200 mM NaCl, 0.025% Tween 20, pH 6.5. After incubation for 5 min at room temperature, 20 μl of the mixtures were loaded into premium coated capillaries and MST data were collected at 22°C under 40% infrared laser power and 50% light-emitting diode power. NanoTemper analysis software (2.1.2) was used to fit the independent experimental data and determine dissociation constants (K d ) and associated errors.
Isothermal titration calorimetry. ITC experiments were carried out at 12°C on a MicroCal ITC200 system (Malvern Instruments) with purified Mtb-SecB TA and ChAD peptide in 20 mM MES, 200 mM NaCl, pH 6.5. The titration protocol comprised a preliminary 0.4 µl injection followed by 19 (resp. 39) consecutive injections of 2 µl (resp. 1 µl) of peptide solution into the sample cell containing the protein. Spacing between each injection was 180 s. Control titrations of peptide solution into the protein-free experimental buffer were also performed. Data were analyzed with MicroCal Origin 5.0 software on the basis of a "one set of sites" which gave the best fit to experimental data. Thermodynamic parameters and errors were obtained from four measurement repeats with concentrations in the range 18-48 µM and 80-620 µM for the protein and the peptide, respectively.
